CD4 and cancer: The CD4 count at the time of diagnosis increased over time for all cancers (360 cells/mm3 [206, 546] in 2006–07, 612 cells/mm3 [402, 839] in 2020–21) and NADCs (399 cells/mm3 [249, 589], 637 cells/mm3 [447, 855]), as shown in Supplementary Figure S2, as well as for infection-related cancers (291 cells/mm3 [160, 447], 514 cells/mm3 [221, 858]).